Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BioAge Labs
Biotech
UPDATE: Lilly-backed metabolic disease biotech files IPO
After raising $170 million back in February, metabolic disease-focused BioAge Labs has filed to debut on the public markets.
Gabrielle Masson
Sep 4, 2024 10:23am
Ex-GSK CEO takes up board post at aging, obesity biotech BioAge
Aug 22, 2024 10:09am
Sands Capital raises new $555M life sci fund
May 14, 2024 10:30am
GLP-1 enthusiasm pushes BioAge into new age with $170M series D
Feb 13, 2024 8:00am
Lilly, BioAge to test muscle regeneration drug with tirzepatide
Oct 26, 2023 11:39am
Former Arena CEO takes over new RNA biotech—Chutes & Ladders
May 26, 2023 9:30am